T. Rowe Price Associates’s Disc Medicine IRON Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $80.3M | Buy |
1,515,625
+157,371
| +12% | +$8.33M | 0.01% | 617 |
|
2025
Q1 | $67.4M | Sell |
1,358,254
-36,383
| -3% | -$1.81M | 0.01% | 634 |
|
2024
Q4 | $88.4M | Buy |
1,394,637
+262,690
| +23% | +$16.7M | 0.01% | 592 |
|
2024
Q3 | $55.6M | Buy |
1,131,947
+9,753
| +0.9% | +$479K | 0.01% | 727 |
|
2024
Q2 | $50.6M | Buy |
1,122,194
+177,981
| +19% | +$8.02M | 0.01% | 721 |
|
2024
Q1 | $58.8M | Buy |
944,213
+353,382
| +60% | +$22M | 0.01% | 686 |
|
2023
Q4 | $34.1M | Buy |
590,831
+63,092
| +12% | +$3.64M | ﹤0.01% | 805 |
|
2023
Q3 | $24.8M | Buy |
527,739
+325,069
| +160% | +$15.3M | ﹤0.01% | 868 |
|
2023
Q2 | $9M | Buy |
+202,670
| New | +$9M | ﹤0.01% | 1090 |
|
2021
Q2 | – | Sell |
-750,000
| Closed | -$9.65M | – | 2932 |
|
2021
Q1 | $9.65M | Buy |
+750,000
| New | +$9.65M | ﹤0.01% | 1398 |
|